ArticleOncoTargets and therapy2020

Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway.

Hongfei Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.